Novel Data Mining Methodology for Healthcare Applied to a New Model to Diagnose Metabolic Syndrome without a Blood Test.
SEMMA
artificial neural networks
decision tree
design methodology
diabetes mellitus
heart disease
holdout
metabolic syndrome
principal component logistic regression
random subsampling
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
15 Nov 2019
15 Nov 2019
Historique:
received:
29
09
2019
revised:
19
10
2019
accepted:
29
10
2019
entrez:
17
11
2019
pubmed:
17
11
2019
medline:
17
11
2019
Statut:
epublish
Résumé
Metabolic Syndrome (MetS) is a cluster of risk factors that increase the likelihood of heart disease and diabetes mellitus. It is crucial to get diagnosed with time to take preventive measures, especially for patients in locations without proper access to laboratories and medical consultations. This work presented a new methodology to diagnose diseases using data mining that documents all the phases thoroughly for further improvement of the resulting models. We used the methodology to create a new model to diagnose the syndrome without using biochemical variables. We compared similar classification models, using their reported variables and previously obtained data from a study in Colombia. We built a new model and compared it to previous models using the holdout, and random subsampling validation methods to get performance evaluation indicators between the models. Our resulting ANN model used three hidden layers and only Hip Circumference, dichotomous Waist Circumference, and dichotomous blood pressure variables. It gave an Area Under Curve (AUC) of 87.75% by the IDF and 85.12% by HMS MetS diagnosis criteria, higher than previous models. Thanks to our new methodology, diagnosis models can be thoroughly documented for appropriate future comparisons, thus benefiting the diagnosis of the studied diseases.
Identifiants
pubmed: 31731612
pii: diagnostics9040192
doi: 10.3390/diagnostics9040192
pmc: PMC6963320
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Metab Syndr Relat Disord. 2018 Oct;16(8):395-405
pubmed: 30063173
BMJ Open. 2017 Nov 8;7(10):e017902
pubmed: 29118053
Diabet Med. 1999 May;16(5):442-3
pubmed: 10342346
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Am J Med. 2006 Oct;119(10):812-9
pubmed: 17000207
Eur J Public Health. 2008 Dec;18(6):656-60
pubmed: 18603599
JAMA. 2015 May 19;313(19):1973-4
pubmed: 25988468
Med Clin (Barc). 2010 Oct 9;135(11):507-11
pubmed: 20206945
Expert Rev Cardiovasc Ther. 2010 Mar;8(3):407-12
pubmed: 20222818
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
Diagnostics (Basel). 2014 Aug 18;4(3):104-28
pubmed: 26852680
Circulation. 2009 Jun 23;119(24):3078-84
pubmed: 19506114
Rev Esp Cardiol. 2011 Jul;64(7):579-86
pubmed: 21640461
Endocr Rev. 2008 Dec;29(7):777-822
pubmed: 18971485
J Clin Endocrinol Metab. 2007 Feb;92(2):399-404
pubmed: 17284640
Diabetes Care. 2012 Nov;35(11):2402-11
pubmed: 23093685
Trends Biotechnol. 2015 Nov;33(11):692-705
pubmed: 26463722
Cardiol Res Pract. 2014;2014:943162
pubmed: 24711954
Appl Nurs Res. 2015 May;28(2):72-7
pubmed: 25908541
J Med Syst. 2016 Dec;40(12):264
pubmed: 27730390
Hypertension. 2003 Dec;42(6):1206-52
pubmed: 14656957
Ann Intern Med. 2004 Feb 3;140(3):167-74
pubmed: 14757614